Beta-Amyloid Impairs Reelin Signaling

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Cuchillo Ibáñez, Inmaculada ^a,b   Balmaceda, Valeria ^a,b   Botella López, Arancha ^a,b   Rabano, Alberto ^b,c   Avila, Jesus ^b,d   Sáez Valero, Javier ^a,b  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c Unidad de Investigacion Proyecto Alzheimer   (Spain)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN RECEPTOR 2; DISABLED 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; LIPOPROTEIN RECEPTOR; MEMBRANE PROTEIN; PROTEIN 14 3 3; REELIN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROPATHOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR OCCUPANCY; SIGNAL TRANSDUCTION; UPREGULATION;

14-3-3 PROTEINS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CELL ADHESION MOLECULES, NEURONAL; CELL LINE; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN MULTIMERIZATION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TAU PROTEINS;

EID: 84881515748     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072297     Document Type: Article

References (42)

1. Rice DS, Curran T, (2001) Role of the reelin signaling pathway in central nervous system development. Annu Rev Neurosci 24: 1005-1039. doi:10.1146/annurev.neuro.24.1.1005. PubMed: 11520926.
2. Tissir F, Goffinet AM, (2003) Reelin and brain development. Nat Rev Neurosci 4: 496-505. doi:10.1038/nrn1113. PubMed: 12778121.
3. Herz J, Chen Y, (2006) Reelin, lipoprotein receptors and synaptic plasticity. Nat Rev Neurosci 7: 850-859. doi:10.1038/nrn2009. PubMed: 17053810.
4. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, et al. (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24: 481-489. doi:10.1016/S0896-6273(00)80861-2. PubMed: 10571241.
5. Brich J, Shie FS, Howell BW, Li R, Tus K, et al. (2003) Genetic modulation of tau phosphorylation in the mouse. J Neurosci 23: 187-192. PubMed: 12514215.
6. Kocherhans S, Madhusudan A, Doehner J, Breu KS, Nitsch RM, et al. (2010) Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice. J Neurosci 30: 9228-9240. doi:10.1523/JNEUROSCI.0418-10.2010. PubMed: 20610758.
7. Chin J, Massaro CM, Palop JJ, Thwin MT, Yu GQ, et al. (2007) Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J Neurosci 27: 2727-2733. doi:10.1523/JNEUROSCI.3758-06.2007. PubMed: 17360894.
8. Hoe HS, Lee KJ, Carney RS, Lee J, Markova A, et al. (2009) Interaction of reelin with amyloid precursor protein promotes neurite outgrowth. J Neurosci 29: 7459-7473. doi:10.1523/JNEUROSCI.4872-08.2009. PubMed: 19515914.
9. Sáez-Valero J, Costell M, Sjögren M, Andreasen N, Blennow K, et al. (2003) Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J Neurosci Res 72: 132-136. doi:10.1002/jnr.10554. PubMed: 12645087.
10. Botella-López A, Burgaya F, Gavín R, García-Ayllón MS, Gómez-Tortosa E, et al. (2006) Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc Natl Acad Sci U S A 103: 5573-5578. doi:10.1073/pnas.0601279103. PubMed: 16567613.
11. Botella-López A, Cuchillo-Ibáñez I, Cotrufo T, Mok SS, Li QX, et al. (2010) Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease. Neurobiol Dis 37: 682-691. doi:10.1016/j.nbd.2009.12.006. PubMed: 20025970.
12. Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, et al. (2011) Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study. Neurobiol Aging 32: 2113-2122. doi:10.1016/j.neurobiolaging.2010.01.010. PubMed: 20452100.
13. Santa-Maria I, Avila J, Rabano A, (2010) Differential gene expression analysis of human entorhinal cortex support a possible role of some extracellular matrix proteins in the onset of Alzheimer disease. Neurosci Lett 468: 225-228. doi:10.1016/j.neulet.2009.11.002. PubMed: 19922771.
14. Lugli G, Krueger JM, Davis JM, Persico AM, Keller F, et al. (2003) Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem 4: 9. doi:10.1186/1471-2091-4-9. PubMed: 12959647.
15. Schägger H, von Jagow G, (1991) Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 199: 223-231. doi:10.1016/0003-2697(91)90094-A. PubMed: 1812789.
16. Kornfeld K, Reitman ML, Kornfeld R, (1981) The carbohydrate-binding specificity of pea and lentil lectins. Fucose is an important determinant. J Biol Chem 256: 6633-6640. PubMed: 7240233.
17. Michel G, Mercken M, Murayama M, Noguchi K, Ishiguro K, et al. (1998) Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells. Biochim Biophys Acta 1380: 177-182. doi:10.1016/S0304-4165(97)00139-6. PubMed: 9565682.
18. D'Arcangelo G, Nakajima K, Miyata T, Ogawa M, Mikoshiba K, et al. (1997) Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J Neurosci 17: 23-31. PubMed: 8987733.
19. Ogawa M, Miyata T, Nakajima K, Yagyu K, Seike M, et al. (1995) The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 14: 899-912. doi:10.1016/0896-6273(95)90329-1. PubMed: 7748558.
20. Sutherland C, Leighton IA, Cohen P, (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 296: 15-19. PubMed: 8250835.
21. Agarwal-Mawal A, Qureshi HY, Cafferty PW, Yuan Z, Han D, et al. (2003) 14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex. J Biol Chem 278: 12722-12728. doi:10.1074/jbc.M211491200. PubMed: 12551948.
22. Yuan Z, Agarwal-Mawal A, Paudel HK, (2004) 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain. J Biol Chem 279: 26105-26114. doi:10.1074/jbc.M308298200. PubMed: 15073173.
23. Strasser V, Fasching D, Hauser C, Mayer H, Bock HH, et al. (2004) Receptor clustering is involved in Reelin signaling. Mol Cell Biol 24: 1378-1386. doi:10.1128/MCB.24.3.1378-1386.2004. PubMed: 14729980.
24. Yasui N, Kitago Y, Beppu A, Kohno T, Morishita S, et al. (2011) Functional importance of covalent homodimer of reelin protein linked via its central region. J Biol Chem 286: 35247-35256. doi:10.1074/jbc.M111.242719. PubMed: 21844191.
25. Utsunomiya-Tate N, Kubo K, Tate S, Kainosho M, Katayama E, et al. (2000) Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc Natl Acad Sci U S A 97: 9729-9734. doi:10.1073/pnas.160272497. PubMed: 10920200.
26. Kubo K, Mikoshiba K, Nakajima K, (2002) Secreted Reelin molecules form homodimers. Neurosci Res 43: 381-388. doi:10.1016/S0168-0102(02)00068-8. PubMed: 12135781.
27. Nyabi O, Bentahir M, Horré K, Herreman A, Gottardi-Littell N, et al. (2003) Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 278(44):: 43430-43436. doi:10.1074/jbc.M306957200. PubMed: 12885769.
28. Xu L, Kappler CS, Mani SK, Shepherd NR, Renaud L, et al. (2009) Chronic administration of KB-R7943 induces up-regulation of cardiac NCX1. J Biol Chem 284: 27265-27272. doi:10.1074/jbc.M109.022855. PubMed: 19661061.
29. Serfo{double acute}zo{double acute} Z, Lontay B, Kukor Z, Erdo{double acute}di F, (2012) Chronic inhibition of nitric oxide synthase activity by N(G)-nitro-L-arginine induces nitric oxide synthase expression in the developing rat cerebellum. Neurochem Int 60: 605-615. doi:10.1016/j.neuint.2012.02.019. PubMed: 22391324.
30. García-Ayllón MS, Silveyra MX, Andreasen N, Brimijoin S, Blennow K, et al. (2007) Cerebrospinal fluid acetylcholinesterase changes after treatment with donepezil in patients with Alzheimer's disease. J Neurochem 101: 1701-1711. doi:10.1111/j.1471-4159.2007.04461.x. PubMed: 17326766.
31. Pennings MT, Derksen RH, van Lummel M, Adelmeijer J, VanHoorelbeke K, et al. (2007) Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2. J Thromb Haemost 5: 369-377. doi:10.1111/j.1538-7836.2007.02310.x. PubMed: 17096706.
32. Senzaki K, Ogawa M, Yagi T, (1999) Proteins of the CNR family are multiple receptors for Reelin. Cell 99: 635-647. doi:10.1016/S0092-8674(00)81552-4. PubMed: 10612399.
33. Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, et al. (2000) Reelin binds alpha3beta1 integrin and inhibits neuronal migration. Neuron 27: 33-44. doi:10.1016/S0896-6273(00)00007-6. PubMed: 10939329.
34. Melander F, Andersson T, Dib K, (2004) Engagement of beta2 integrins recruits 14-3-3 proteins to c-Cbl in human neutrophils. Biochem Biophys Res Commun 317: 1000-1005. doi:10.1016/j.bbrc.2004.03.147. PubMed: 15094368.
35. Fountoulakis M, Cairns N, Lubec G, (1999) Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 57: 323-335. PubMed: 10666687.
36. Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt JJ, et al. (2009) Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease. J Proteome Res 8: 5069-5079. doi:10.1021/pr900474t. PubMed: 19746990.
37. Nakagawa K, Kitazume S, Oka R, Maruyama K, Saido TC, et al. (2006) Sialylation enhances the secretion of neurotoxic amyloid-beta peptides. J Neurochem 96: 924-933. doi:10.1111/j.1471-4159.2005.03595.x. PubMed: 16412100.
38. Sidera C, Parsons R, Austen B, (2005) Post-translational processing of beta-secretase in Alzheimer's disease. Proteomics 5: 1533-1543. doi:10.1002/pmic.200401185. PubMed: 15789346.
39. Yang DS, Tandon A, Chen F, Yu G, Yu H, et al. (2002) Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J Biol Chem 277: 28135-28142. doi:10.1074/jbc.M110871200. PubMed: 12032140.
40. May P, Bock HH, Nimpf J, Herz J, (2003) Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. J Biol Chem 278: 37386-37392. doi:10.1074/jbc.M305858200. PubMed: 12871934.
41. Liu F, Iqbal K, Grundke-Iqbal I, Hart GW, Gong CX, (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc Natl Acad Sci U S A 101: 10804-10809. doi:10.1073/pnas.0400348101. PubMed: 15249677.
42. Wang JZ, Grundke-Iqbal I, Iqbal K, (1996) Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease. Nat Med 2: 871-875. doi:10.1038/nm0896-871. PubMed: 8705855.